SMARCAD1
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
39938single nucleotide variantSMARCAD1, IVS1, G-T, +1-1MedGen:C1851080,OMIM:136000na-1-1nana
185674single nucleotide variantSMARCAD1, IVS1, G-A, +1-1MedGen:C1851080,OMIM:136000na-1-1nana
185675single nucleotide variantSMARCAD1, IVS1, T-C, +2-1MedGen:C1851080,OMIM:136000na-1-1nana
185676single nucleotide variantSMARCAD1, IVS1, G-C, +5-1MedGen:C1851080,OMIM:136000na-1-1nana
185677single nucleotide variantSMARCAD1, IVS1, A-T, +3-1MedGen:CN221809na-1-1nana
359630single nucleotide variantNM_001128429.2(SMARCAD1):c.304G>A (p.Val102Ile)200948051MedGen:CN16937449422623294226232GA
359630single nucleotide variantNM_001128429.2(SMARCAD1):c.304G>A (p.Val102Ile)200948051MedGen:CN16937449514738395147383GA
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
495153349rs3106136TCrs31061367.00E-06CAPECITABINE|FLUOROURACILANTIMETABOLITES, ANTINEOPLASTIC|DEOXYCYTIDINECapecitabine sensitivityHPOID:0003002|HPOID:0002672DOID:9256|DOID:1612|DOID:5517AintronGWASdb_drug
495128677rs17374902TCrs173749021.31E-04Type 2 diabetesHPOID:0005978DOID:9352TnearGene-5GWASdb_trait
495146135rs11097407GCrs110974074.00E-06Bipolar disorder and schizophreniaHPOID:0007302|HPOID:0100753DOID:3312|DOID:5419GintronGWASdb_trait
495146135rs11097407GCrs110974072.46E-05SchizophreniaHPOID:0100753DOID:5419GintronGWASdb_trait
495146281rs2664871CTrs26648712.06E-05Bipolar disorder and schizophreniaHPOID:0007302|HPOID:0100753DOID:3312|DOID:5419CintronGWASdb_trait
495146281rs2664871CTrs26648712.59E-05SchizophreniaHPOID:0100753DOID:5419CintronGWASdb_trait
495147055rs2632401CGrs26324011.02E-05Bipolar disorder and schizophreniaHPOID:0007302|HPOID:0100753DOID:3312|DOID:5419CintronGWASdb_trait
495147055rs2632401CGrs26324011.74E-05SchizophreniaHPOID:0100753DOID:5419CintronGWASdb_trait
495152413rs17303283TCrs173032835.16E-06Waist-Hip RatioHPOID:0001513DOID:9970TintronGWASdb_trait
495153349rs3106136TCrs31061367.00E-06Capecitabine sensitivityHPOID:0003002|HPOID:0002672DOID:9256|DOID:1612|DOID:5517AintronGWASdb_trait
495162960rs2087170TGrs20871703.03E-05Bipolar disorder and schizophreniaHPOID:0007302|HPOID:0100753DOID:3312|DOID:5419AintronGWASdb_trait
495162960rs2087170TGrs20871703.46E-05SchizophreniaHPOID:0100753DOID:5419AintronGWASdb_trait
495168607rs10516948CArs105169481.75E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
495169266rs10032125CTrs100321251.23E-04Type 2 diabetesHPOID:0005978DOID:9352TintronGWASdb_trait
495183216rs12646184CTrs126461841.19E-05Bipolar disorder and schizophreniaHPOID:0007302|HPOID:0100753DOID:3312|DOID:5419CintronGWASdb_trait
495183216rs12646184CTrs126461841.96E-05SchizophreniaHPOID:0100753DOID:5419CintronGWASdb_trait
495192461rs6532476CArs65324767.19E-05ldl cholesterolHPOID:0010979DOID:1936|DOID:3393AintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000163104.17 SMARCAD1 612761